411 related articles for article (PubMed ID: 33671306)
1. Potential Treatment of Lysosomal Storage Disease through Modulation of the Mitochondrial-Lysosomal Axis.
Kuk MU; Lee YH; Kim JW; Hwang SY; Park JT; Park SC
Cells; 2021 Feb; 10(2):. PubMed ID: 33671306
[TBL] [Abstract][Full Text] [Related]
2. The intersection of lysosomal and endoplasmic reticulum calcium with autophagy defects in lysosomal diseases.
Liu EA; Lieberman AP
Neurosci Lett; 2019 Apr; 697():10-16. PubMed ID: 29704574
[TBL] [Abstract][Full Text] [Related]
3. Adjustment of the lysosomal-mitochondrial axis for control of cellular senescence.
Park JT; Lee YS; Cho KA; Park SC
Ageing Res Rev; 2018 Nov; 47():176-182. PubMed ID: 30142381
[TBL] [Abstract][Full Text] [Related]
4. SnapShot: Lysosomal Storage Diseases.
Martina JA; Raben N; Puertollano R
Cell; 2020 Feb; 180(3):602-602.e1. PubMed ID: 32032518
[TBL] [Abstract][Full Text] [Related]
5. Aberrant autophagy in lysosomal storage disorders marked by a lysosomal SNARE protein shortage due to suppression of endocytosis.
Tanaka H; Tsuji D; Watanabe R; Ohnishi Y; Kitaguchi S; Nakae R; Teramoto H; Tsukimoto J; Horii Y; Itoh K
J Inherit Metab Dis; 2022 Nov; 45(6):1191-1202. PubMed ID: 36102069
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal positioning diseases: beyond substrate storage.
Scerra G; De Pasquale V; Scarcella M; Caporaso MG; Pavone LM; D'Agostino M
Open Biol; 2022 Oct; 12(10):220155. PubMed ID: 36285443
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders.
Fraldi A; Annunziata F; Lombardi A; Kaiser HJ; Medina DL; Spampanato C; Fedele AO; Polishchuk R; Sorrentino NC; Simons K; Ballabio A
EMBO J; 2010 Nov; 29(21):3607-20. PubMed ID: 20871593
[TBL] [Abstract][Full Text] [Related]
8. Autophagy, mitochondria and cell death in lysosomal storage diseases.
Kiselyov K; Jennigs JJ; Rbaibi Y; Chu CT
Autophagy; 2007; 3(3):259-62. PubMed ID: 17329960
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.
Plotegher N; Duchen MR
Trends Mol Med; 2017 Feb; 23(2):116-134. PubMed ID: 28111024
[TBL] [Abstract][Full Text] [Related]
10. Monitoring autophagy in lysosomal storage disorders.
Raben N; Shea L; Hill V; Plotz P
Methods Enzymol; 2009; 453():417-49. PubMed ID: 19216919
[TBL] [Abstract][Full Text] [Related]
11. Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease.
Lim JA; Li L; Kakhlon O; Myerowitz R; Raben N
Autophagy; 2015; 11(2):385-402. PubMed ID: 25758767
[TBL] [Abstract][Full Text] [Related]
12. A polylysine-polyhistidine fusion peptide for lysosome-targeted protein delivery.
Iwasaki T; Murakami N; Kawano T
Biochem Biophys Res Commun; 2020 Dec; 533(4):905-912. PubMed ID: 33008588
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal storage diseases as disorders of autophagy.
Settembre C; Fraldi A; Rubinsztein DC; Ballabio A
Autophagy; 2008 Jan; 4(1):113-4. PubMed ID: 18000397
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial breakdown in skeletal muscle and the emerging role of the lysosomes.
Triolo M; Hood DA
Arch Biochem Biophys; 2019 Jan; 661():66-73. PubMed ID: 30439362
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Ca2+ homeostasis in lysosomal storage diseases.
Kiselyov K; Muallem S
Cell Calcium; 2008 Jul; 44(1):103-11. PubMed ID: 18242695
[TBL] [Abstract][Full Text] [Related]
16. Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases.
Saffari A; Kölker S; Hoffmann GF; Ebrahimi-Fakhari D
J Inherit Metab Dis; 2017 Sep; 40(5):631-640. PubMed ID: 28477283
[TBL] [Abstract][Full Text] [Related]
17. A block of autophagy in lysosomal storage disorders.
Settembre C; Fraldi A; Jahreiss L; Spampanato C; Venturi C; Medina D; de Pablo R; Tacchetti C; Rubinsztein DC; Ballabio A
Hum Mol Genet; 2008 Jan; 17(1):119-29. PubMed ID: 17913701
[TBL] [Abstract][Full Text] [Related]
18. Common and uncommon pathogenic cascades in lysosomal storage diseases.
Vitner EB; Platt FM; Futerman AH
J Biol Chem; 2010 Jul; 285(27):20423-7. PubMed ID: 20430897
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal targeting strategies for design and delivery of bioactive for therapeutic interventions.
Sharma A; Vaghasiya K; Ray E; Verma RK
J Drug Target; 2018 Mar; 26(3):208-221. PubMed ID: 28862054
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis.
Fernandez-Mosquera L; Yambire KF; Couto R; Pereyra L; Pabis K; Ponsford AH; Diogo CV; Stagi M; Milosevic I; Raimundo N
Autophagy; 2019 Sep; 15(9):1572-1591. PubMed ID: 30917721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
